HomeCompareKLKBF vs MRK

KLKBF vs MRK: Dividend Comparison 2026

KLKBF yields 2.42% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KLKBF wins by $7.1K in total portfolio value· pulled ahead in Year 9
10 years
KLKBF
KLKBF
● Live price
2.42%
Share price
$6.17
Annual div
$0.15
5Y div CAGR
38.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.9K
Annual income
$15,295.08
Full KLKBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KLKBF vs MRK

📍 KLKBF pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKLKBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KLKBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KLKBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KLKBF
Annual income on $10K today (after 15% tax)
$205.65/yr
After 10yr DRIP, annual income (after tax)
$13,000.82/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KLKBF beats the other by $4,672.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KLKBF + MRK for your $10,000?

KLKBF: 50%MRK: 50%
100% MRK50/50100% KLKBF
Portfolio after 10yr
$60.3K
Annual income
$12,546.61/yr
Blended yield
20.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KLKBF
No analyst data
Altman Z
2.5
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KLKBF buys
0
MRK buys
0
No recent congressional trades found for KLKBF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKLKBFMRK
Forward yield2.42%2.76%
Annual dividend / share$0.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.3%32.7%
Portfolio after 10y$63.9K$56.8K
Annual income after 10y$15,295.08$9,798.13
Total dividends collected$39.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KLKBF vs MRK ($10,000, DRIP)

YearKLKBF PortfolioKLKBF Income/yrMRK PortfolioMRK Income/yrGap
1$11,035$334.61$11,206$366.19$171.00MRK
2$12,284$477.24$12,650$502.35$366.00MRK
3$13,831$686.70$14,407$694.19$576.00MRK
4$15,798$999.32$16,585$967.82$787.00MRK
5$18,380$1,475.38$19,342$1,363.89$962.00MRK
6$21,885$2,218.54$22,913$1,947.19$1.0KMRK
7$26,831$3,414.37$27,662$2,823.89$831.00MRK
8$34,120$5,410.59$34,159$4,173.35$39.00MRK
9← crossover$45,401$8,893.08$43,337$6,308.80+$2.1KKLKBF
10$63,874$15,295.08$56,776$9,798.13+$7.1KKLKBF

KLKBF vs MRK: Complete Analysis 2026

KLKBFStock

Kuala Lumpur Kepong Berhad engages in the plantation, manufacturing, and property development businesses. The company operates through Plantation, Manufacturing, Property Development, Investment Holding, and Others segments. It is involved in the cultivation, processing, and marketing of palm and rubber products; extraction of crude palm oil; refining of palm products; kernel crushing and trading of palm products; manufacturing and trading in oleochemicals, fatty acids, glycerin, industrial amides, fatty alcohol and methyl esters, non-ionic surfactants and esters, soap noodles, triacetin, special paper chemicals and surfactants, and palm phytonutrients and other palm derivatives; detergents, auxiliary materials for detergents and cosmetics, and basic organic chemicals from agricultural products; and alcohol ether sulphates, alcohol sulphates, and sulphonic acids. The company also provides rubber gloves, parquet flooring products, pharmaceutical and bio-pharmaceutical intermediates, and fine chemicals, as well as stores and distributes bulk liquid. In addition, it engages in farming and management services; and agronomic service and research, as well as operates biogas power plants; and develops residential and commercial properties. Further, the company operates holiday bungalows; manages properties; manufactures jams and preserves; and offers offshore captive insurance and logistics services related to palm products. It operates in Malaysia, Far East, the Middle East, South East Asia, Southern Asia, Europe, North America, South America, Australia, Africa, and internationally. The company was founded in 1906 and is based in Ipoh, Malaysia.

Full KLKBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KLKBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KLKBF vs SCHDKLKBF vs JEPIKLKBF vs OKLKBF vs KOKLKBF vs MAINKLKBF vs JNJKLKBF vs ABBVKLKBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.